Evidence map›Paper›PMID 37584111›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2023

Validation of Childhood Pneumonia Prognostic Models for Use in Emergency Care Settings.

James W Antoon, Hui Nian, Krow Ampofo, Yuwei Zhu, Laura F Sartori, Jakobi Johnson, Donald H Arnold, Justine Stassun, Andrew T Pavia, Carlos G Grijalva and 1 more

Abstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James W AntoonDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.ORCID 0000-0001-6188-2658
Hui NianDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Krow AmpofoDepartment of Pediatrics, University of Utah School of Medicine, Nashville, Tennessee, USA.
Yuwei ZhuDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Laura F SartoriDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Jakobi JohnsonDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Donald H ArnoldDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Justine StassunDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Andrew T PaviaDepartment of Pediatrics, University of Utah School of Medicine, Nashville, Tennessee, USA.ORCID 0000-0002-3066-580X
Carlos G GrijalvaDepartments of Health Policy and Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Derek J WilliamsDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Funding

Risk Stratification and Decision Support to Improve Care and Outcomes in Children with PneumoniaR01AI125642 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILLIAMS, DEREK J. · 2017 to 2021
$3.3M
Mentoring in transmission of influenza and strategies for preventionK24AI148459 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GRIJALVA, CARLOS G · 2020 to 2024
$893k
Oseltamivir Use and Risk of Serious Neuropsychiatric Adverse Events in ChildrenK23AI168496 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ANTOON, JAMES W · 2022 to 2025
$740k
Development and Validation of a Clinical Prediction Rule for Pediatric PneumoniaK23AI104779 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILLIAMS, DEREK J. · 2013 to 2016
$688k
NIAID NIH HHS K23 AI104779NIAID NIH HHS K23 AI168496NIAID NIH HHS K24 AI148459NIAID NIH HHS R01 AI125642
6 · The paper itself

Abstract

backgroundUnwarranted variation in disposition decisions exist among children with pneumonia. We validated three prognostic models for predicting pneumonia severity among children in the emergency department (ED) and hospital.

methodsWe performed a two-center, prospective study of children 6 months to <18 years presenting to the ED with pneumonia from January 2014 to May 2019. We evaluated three previously developed disease-specific prognostic models which use demographic, clinical, and diagnostic predictor variables, with each model estimating risk for Very Severe (mechanical ventilation or shock), Severe (ICU without very severe features), and Moderate/Mild (Hospitalization without severe features or ED discharge) pneumonia. Predictive accuracy was measured using discrimination (concordance or c-statistic) and re-calibration.

resultsThere were 1088 children included in one or more of the three models. Median age was 3.6 years and the majority of children were male (53.7%) and identified as non-Hispanic White (63.7%). The distribution for the ordinal severity outcome was mild or moderate (79.1%), severe (15.9%), and very severe (4.9%). The three models each demonstrated excellent discrimination (C-statistic range across models [0.786-0.803]) with no appreciable degradation in predictive accuracy from the derivation cohort.

conclusionsAll three prognostic models accurately identified risk for three clinically meaningful levels of pneumonia severity and demonstrated very good predictive performance. Physiologic variables contributed the most to model prediction. Application of these objective tools may help standardize and improve disposition and other management decisions for children with pneumonia.

Indexed as

Emergency Medical ServicesPneumoniaChildChild, PreschoolFemaleHospitalizationHumansMalePrognosisProspective Studiespediatricspneumoniaprognostic modelvalidation

Identifiers

PMID37584111
PMCPMC10469586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.